In September 2024, Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the launch of its new liquid-phase peptide synthesis (LPPS) technology.

By synthesis technology, the liquid phase peptide synthesis (LPPS) segment has recorded the largest market share of 45.87% in 2024.

The most common synthesis routes consist of either solid-phase peptide synthesis (SPPS) or liquid-phase peptide synthesis (such as GnRH analogues). In SPPS, the peptide chain is built one amino ...

The new facility in Switzerland will also dovetail with the company’s expansion of its Boulder site in Colorado, doubling CordenPharma's annual solid phase peptide synthesis (SPPS) reactor ...